+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Hyaluronic Acid-based Dermal Fillers Market Research Report by Product (Duplex Product and Single-Phase Product), Application, State - United States Forecast to 2027 - Cumulative Impact of COVID-19

  • ID: 5532870
  • Report
  • April 2022
  • Region: United States
  • 109 Pages
  • 360iResearch™
UP TO OFF until Dec 31st 2022
The United States Hyaluronic Acid-based Dermal Fillers Market size was estimated at USD 991.98 million in 2021, USD 1,047.65 million in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 7.57% to reach USD 1,536.94 million by 2027.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Hyaluronic Acid-based Dermal Fillers to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Product, the market was studied across Duplex Product and Single-Phase Product.
  • Based on Application, the market was studied across Lip Augmentation, Rhinoplasty, and Wrinkle Removal.
  • Based on State, the market was studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Hyaluronic Acid-based Dermal Fillers Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the United States Hyaluronic Acid-based Dermal Fillers Market, including AbbVie Inc., Adoderm GmbH, Anika Therapeutics, Inc., Bio Plus Co., Ltd., Bioxis Pharmaceuticals, Bloomage Biotechnology Corp. Ltd., Bohus Biotech AB, Croma-Pharma GmbH, Cynosure LLC, Dr. Korman Laboratories Ltd., Galderma Laboratories L.P., Genzyme Corporation, HUGEL, Inc., Inamed Corporation, Laboratoires Vivacy, LG Life Sciences, Ltd., Medicis Aesthetics Holdings Inc., Medy Tox Inc, Merz Pharmaceuticals, Sculpt Luxury Dermal Fillers Ltd, Sinclair Pharma, and Teoxane SA.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the United States Hyaluronic Acid-based Dermal Fillers Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Hyaluronic Acid-based Dermal Fillers Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Hyaluronic Acid-based Dermal Fillers Market?
4. What is the competitive strategic window for opportunities in the United States Hyaluronic Acid-based Dermal Fillers Market?
5. What are the technology trends and regulatory frameworks in the United States Hyaluronic Acid-based Dermal Fillers Market?
6. What is the market share of the leading vendors in the United States Hyaluronic Acid-based Dermal Fillers Market?
7. What modes and strategic moves are considered suitable for entering the United States Hyaluronic Acid-based Dermal Fillers Market?
Frequently Asked Questions about the U.S. Hyaluronic Acid-based Dermal Fillers Market

What is the estimated value of the U.S. Hyaluronic Acid-based Dermal Fillers Market?

The U.S. Hyaluronic Acid-based Dermal Fillers Market was estimated to be valued at $992.0 Million in 2021.

What is the growth rate of the U.S. Hyaluronic Acid-based Dermal Fillers Market?

The growth rate of the U.S. Hyaluronic Acid-based Dermal Fillers Market is 7.5%, with an estimated value of $1536.9 Million by 2027.

What is the forecasted size of the U.S. Hyaluronic Acid-based Dermal Fillers Market?

The U.S. Hyaluronic Acid-based Dermal Fillers Market is estimated to be worth $1536.9 Million by 2027.

Who are the key companies in the U.S. Hyaluronic Acid-based Dermal Fillers Market?

Key companies in the U.S. Hyaluronic Acid-based Dermal Fillers Market include AbbVie Inc., Adoderm GmbH, Anika Therapeutics, Inc., Bio Plus Co., Ltd., Bioxis Pharmaceuticals, Bloomage Biotechnology Corp. Ltd., Bohus Biotech AB, Croma and Cynosure LLC.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Cumulative Impact of COVID-19
6. Hyaluronic Acid-based Dermal Fillers Market, by Product
6.1. Introduction
6.2. Duplex Product
6.3. Single-Phase Product
7. Hyaluronic Acid-based Dermal Fillers Market, by Application
7.1. Introduction
7.2. Lip Augmentation
7.3. Rhinoplasty
7.4. Wrinkle Removal
8. California Hyaluronic Acid-based Dermal Fillers Market9. Florida Hyaluronic Acid-based Dermal Fillers Market10. Illinois Hyaluronic Acid-based Dermal Fillers Market11. New York Hyaluronic Acid-based Dermal Fillers Market12. Ohio Hyaluronic Acid-based Dermal Fillers Market13. Pennsylvania Hyaluronic Acid-based Dermal Fillers Market14. Texas Hyaluronic Acid-based Dermal Fillers Market
15. Competitive Landscape
15.1. FPNV Positioning Matrix
15.1.1. Quadrants
15.1.2. Business Strategy
15.1.3. Product Satisfaction
15.2. Market Ranking Analysis
15.3. Market Share Analysis, By Key Player
15.4. Competitive Scenario
15.4.1. Merger & Acquisition
15.4.2. Agreement, Collaboration, & Partnership
15.4.3. New Product Launch & Enhancement
15.4.4. Investment & Funding
15.4.5. Award, Recognition, & Expansion
16. Company Usability Profiles
16.1. AbbVie Inc.
16.2. Adoderm GmbH
16.3. Anika Therapeutics, Inc.
16.4. Bio Plus Co., Ltd.
16.5. Bioxis Pharmaceuticals
16.6. Bloomage Biotechnology Corp. Ltd.
16.7. Bohus Biotech AB
16.8. Croma-Pharma GmbH
16.9. Cynosure LLC
16.10. Dr. Korman Laboratories Ltd.
16.11. Galderma Laboratories L.P.
16.12. Genzyme Corporation
16.13. HUGEL, Inc.
16.14. Inamed Corporation
16.15. Laboratoires Vivacy
16.16. LG Life Sciences, Ltd.
16.17. Medicis Aesthetics Holdings Inc.
16.18. Medy Tox Inc
16.19. Merz Pharmaceuticals
16.20. Sculpt Luxury Dermal Fillers Ltd
16.21. Sinclair Pharma
16.22. Teoxane SA
17. Appendix
17.1. Discussion Guide
17.2. License & Pricing
List of Figures
FIGURE 1. UNITED STATES HYALURONIC ACID-BASED DERMAL FILLERS MARKET: DYNAMICS
FIGURE 2. UNITED STATES HYALURONIC ACID-BASED DERMAL FILLERS MARKET SIZE, BY PRODUCT, 2021 VS 2027 (%)
FIGURE 3. UNITED STATES HYALURONIC ACID-BASED DERMAL FILLERS MARKET SIZE, BY PRODUCT, 2021 VS 2027 (USD MILLION)
FIGURE 4. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES HYALURONIC ACID-BASED DERMAL FILLERS MARKET SIZE, BY PRODUCT, 2027
FIGURE 5. UNITED STATES HYALURONIC ACID-BASED DERMAL FILLERS MARKET SIZE, BY DUPLEX PRODUCT, 2019-2027 (USD MILLION)
FIGURE 6. UNITED STATES HYALURONIC ACID-BASED DERMAL FILLERS MARKET SIZE, BY DUPLEX PRODUCT, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 7. UNITED STATES HYALURONIC ACID-BASED DERMAL FILLERS MARKET SIZE, BY SINGLE-PHASE PRODUCT, 2019-2027 (USD MILLION)
FIGURE 8. UNITED STATES HYALURONIC ACID-BASED DERMAL FILLERS MARKET SIZE, BY SINGLE-PHASE PRODUCT, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 9. UNITED STATES HYALURONIC ACID-BASED DERMAL FILLERS MARKET SIZE, BY APPLICATION, 2021 VS 2027 (%)
FIGURE 10. UNITED STATES HYALURONIC ACID-BASED DERMAL FILLERS MARKET SIZE, BY APPLICATION, 2021 VS 2027 (USD MILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES HYALURONIC ACID-BASED DERMAL FILLERS MARKET SIZE, BY APPLICATION, 2027
FIGURE 12. UNITED STATES HYALURONIC ACID-BASED DERMAL FILLERS MARKET SIZE, BY LIP AUGMENTATION, 2019-2027 (USD MILLION)
FIGURE 13. UNITED STATES HYALURONIC ACID-BASED DERMAL FILLERS MARKET SIZE, BY LIP AUGMENTATION, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 14. UNITED STATES HYALURONIC ACID-BASED DERMAL FILLERS MARKET SIZE, BY RHINOPLASTY, 2019-2027 (USD MILLION)
FIGURE 15. UNITED STATES HYALURONIC ACID-BASED DERMAL FILLERS MARKET SIZE, BY RHINOPLASTY, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 16. UNITED STATES HYALURONIC ACID-BASED DERMAL FILLERS MARKET SIZE, BY WRINKLE REMOVAL, 2019-2027 (USD MILLION)
FIGURE 17. UNITED STATES HYALURONIC ACID-BASED DERMAL FILLERS MARKET SIZE, BY WRINKLE REMOVAL, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 18. UNITED STATES HYALURONIC ACID-BASED DERMAL FILLERS MARKET: FPNV POSITIONING MATRIX
FIGURE 19. UNITED STATES HYALURONIC ACID-BASED DERMAL FILLERS MARKET: SHARE, BY KEY PLAYER, 2021
FIGURE 20. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES HYALURONIC ACID-BASED DERMAL FILLERS MARKET, BY TYPE
List of Tables
TABLE 1. UNITED STATES HYALURONIC ACID-BASED DERMAL FILLERS MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. UNITED STATES HYALURONIC ACID-BASED DERMAL FILLERS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 4. UNITED STATES HYALURONIC ACID-BASED DERMAL FILLERS MARKET SIZE, BY DUPLEX PRODUCT, BY STATE, 2019-2027 (USD MILLION)
TABLE 5. UNITED STATES HYALURONIC ACID-BASED DERMAL FILLERS MARKET SIZE, BY SINGLE-PHASE PRODUCT, BY STATE, 2019-2027 (USD MILLION)
TABLE 6. UNITED STATES HYALURONIC ACID-BASED DERMAL FILLERS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 7. UNITED STATES HYALURONIC ACID-BASED DERMAL FILLERS MARKET SIZE, BY LIP AUGMENTATION, BY STATE, 2019-2027 (USD MILLION)
TABLE 8. UNITED STATES HYALURONIC ACID-BASED DERMAL FILLERS MARKET SIZE, BY RHINOPLASTY, BY STATE, 2019-2027 (USD MILLION)
TABLE 9. UNITED STATES HYALURONIC ACID-BASED DERMAL FILLERS MARKET SIZE, BY WRINKLE REMOVAL, BY STATE, 2019-2027 (USD MILLION)
TABLE 10. UNITED STATES HYALURONIC ACID-BASED DERMAL FILLERS MARKET: SCORES
TABLE 11. UNITED STATES HYALURONIC ACID-BASED DERMAL FILLERS MARKET: BUSINESS STRATEGY
TABLE 12. UNITED STATES HYALURONIC ACID-BASED DERMAL FILLERS MARKET: PRODUCT SATISFACTION
TABLE 13. UNITED STATES HYALURONIC ACID-BASED DERMAL FILLERS MARKET: RANKING
TABLE 14. UNITED STATES HYALURONIC ACID-BASED DERMAL FILLERS MARKET: SHARE, BY KEY PLAYER, 2021
TABLE 15. UNITED STATES HYALURONIC ACID-BASED DERMAL FILLERS MARKET: MERGER & ACQUISITION
TABLE 16. UNITED STATES HYALURONIC ACID-BASED DERMAL FILLERS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 17. UNITED STATES HYALURONIC ACID-BASED DERMAL FILLERS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 18. UNITED STATES HYALURONIC ACID-BASED DERMAL FILLERS MARKET: INVESTMENT & FUNDING
TABLE 19. UNITED STATES HYALURONIC ACID-BASED DERMAL FILLERS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 20. UNITED STATES HYALURONIC ACID-BASED DERMAL FILLERS MARKET: LICENSE & PRICING

Companies Mentioned

  • AbbVie Inc.
  • Adoderm GmbH
  • Anika Therapeutics, Inc.
  • Bio Plus Co., Ltd.
  • Bioxis Pharmaceuticals
  • Bloomage Biotechnology Corp. Ltd.
  • Bohus Biotech AB
  • Croma-Pharma GmbH
  • Cynosure LLC
  • Dr. Korman Laboratories Ltd.
  • Galderma Laboratories L.P.
  • Genzyme Corporation
  • HUGEL, Inc.
  • Inamed Corporation
  • Laboratoires Vivacy
  • LG Life Sciences, Ltd.
  • Medicis Aesthetics Holdings Inc.
  • Medy Tox Inc
  • Merz Pharmaceuticals
  • Sculpt Luxury Dermal Fillers Ltd
  • Sinclair Pharma
  • Teoxane SA

Methodology

Loading
LOADING...